Introduction
To mediate dosage compensation, one of the two X chromosomes of female mammals is inactivated (1, 2). This process, which is called X inactivation, is normally random in the soma of eutherian mammals while it is parent of origin-dependent in the extra-embryonic tissues (3, 4) . Genetic dissection has revealed that X-inactivation involves a complicated set of events that culminates in the activation of XIST on the future inactive X chromosome (5) .
The XIST transcript subsequently coats the chromatin fibre to irreversibly induce the inactive state along the bulk of the chosen X chromosome in somatic cells (6, 7).
Although the mechanisms underlying the activation of XIST remain poorly understood, they are likely to involve the antisense non-coding transcript Tsix (8) , since deletion of the Tsix gene or regulatory elements controlling Tsix expression leads to skewed X inactivation (8, 9) . In a more recent study Ogawa et al. functionally characterized the "Xinactivation intergenic transcription elements" (Xite) region (10) . Xite is candidate enhancer element possibly regulated by tandem CTCF-binding sites in a chromatin-insulator within the Tsix/DXPas34 region (11) . While the mouse Tsix/DXPas34 region contains greater than 40 CTCF motifs, the corresponding region of the human X chromosome has greater than 10 similar sites (11) . However, not only regions of Xist can affect XCI: Further characterization of the 5' end of the Xist locus revealed specific zones of non-coding transcription where a series of targeted deletions and mutations also results in a pattern of XCI skewing like that resulting from deletions in the Xite or Tsix/DXPas34 regions (12) . Thus, there are perhaps several additional candidate regions on both sides of Xist, which together may define a 5 CTCF is a highly conserved chromatin protein already implicated in a remarkably diverse number of functions, including regulation of imprinted genes in soma, and of X chromosome inactivation in mice (11, 15, 16) . Different functions of CTCF appear to be mediated by binding to highly dissimilar ~ 50-bp-long target sequences by engaging varying combinations of its 11 ZFs in establishing specific DNA base contacts. Since CTCFcontacting DNA base motifs have no single consensus that would allow one to reliably predict novel CTCF target sites (15), we initially utilized recombinant CTCF to map and characterize its interactions with the wild type and mutant human XIST promoters in vitro. In addition, we studied binding of CTCF to the wild type human and mouse XIST/Xist promoters in vivo. We demonstrate here that CTCF binds with a similar, relatively modest affinity to the same region of sequence homology in mouse, rabbit, horse and human XIST wild-type promoters (17) , while the C(-43)G and C(-43)A mutations display increased and absence of CTCF binding, respectively.
Based on the facts that CTCF efficiently interacts with itself to mediate site-specific heterodimerization of CTCF/DNA-complexes (18) and that CTCF is in vivo associated with the active Xist promoter on only the inactive X chromosome, we discuss the possibility that the inherited point mutations at position -43 of the XIST promoter may pre-empt X chromosome inactivation choice by facilitating the formation of a higher order chromatin conformation permissive for XIST transcription.
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The mouse/human Xist/XIST promoters are specifically recognized by the multivalent 11
Zn-finger (ZF) DNA binding domain of CTCF
Attempts to predict CTCF-binding sequences, solely based on homology with the known targets, often results in finding of such sequences among numerous genomic regions previously tested experimentally negative for CTCF binding (19) . We carried out therefore, a direct systematic search for CTCF-binding sites by using recombinant CTCF protein an electrophoretic mobility shift assays (EMSA) with two sets of eight consecutive overlapping DNA probes. One set of EMSA probes spanned the XIST promoter of human origin (Fig. 1B) , whereas a similar set of probes covered the promoter from Mus musculus domesticus (Fig.   1C ).
CTCF sites can be missed by conventional EMSA with DNA-probes made as 20-to 60-bp-long double-stranded oligonucleotides. These probes are too short to accommodate binding of the 11 ZF domain that generates approximately 50-60-bp-long DNAse I footprints on each strand with each individual ZF (plus the linker) requiring up to 5-6 bases of DNA for the efficient binding (20) . Therefore, each set of 32 P-end-labeled DNA-probes used in Figure   1 was designed to include a 120-250-bp-long overlapping DNA fragments. In addition, the overlapping of DNA-fragments were designed such that an additional flanking DNA around ~ 50-bp of a putative CTCF-binding sequence would become included in one of two consecutive fragments.
In both screens (Fig. 1B, C CTCF in normal cells (15, 22) . This experiment revealed that only female human cells, regardless of their origin, had CTCF bound to Xist promoter in vivo. In contrast, the control (N-site) has been pulled down equally well by CTCF antibody from both male and female cells. This result could be extended to freshly isolated peripheral blood leukocytes (PBL) from healthy male and female donors for ChIP analyses. Figure 2B illustrates a 6-7 fold To examine more closely the possibility of a specific in vivo association between CTCF and the Xist allele of only inactive X chromosome in mammalian female cells, we turned our attention to the female mouse placenta, a tissue that exhibits selective inactivation of the paternal X chromosome. Dispersed, formaldehyde-crosslinked placental cells were subjected to chromatin immunoprecipitation (ChIP) analysis using affinity-purified rabbit polyclonal antibodies against the C-terminal portion of CTCF (23) . Figure 2C shows results of the ChIP assays comparing a positive, internal control, the maternal H19 ICR allele that interacts constitutively with CTCF in vivo (23) with the Xist promoter region positive for CTCF-binding in the in vitro EMSA (Fig. 1C) . These results show that the CTCF antibody pulled down both the H19 ICR and Xist promoter fragments from female placenta, while only the H19 ICR could be recovered in CTCF ChIP material derived from the male placenta.
These results agree well with the ChIP data from the human cells, reinforcing the possibility that CTCF was associated with the Xist promoter sequence of only the inactive X chromosome. To directly examine this contention, CTCF ChIP DNA samples derived from female placenta of interspecific M. musculus and M. spretus crosses were sequenced directly.
This approach exploited an A/C polymorphism at position -88 upstream of the transcriptional start site of the Xist gene in M. musculus (C57BL/6J) compared with M. spretus allowing us to distinguish a maternally inherited allele from a paternally inherited allele in mouse placentas from female F1 mice. Figure 2D shows that the CTCF antibody pulled down only the paternally inherited allele (M. spretus), confirming our supposition that CTCF is 9 associated only with the Xist promoter of the inactive X chromosome in female mouse placentas and, by extrapolation, also to female humans.
Germline mutations of the CTCF target sequence in the XIST promoter in families with skewed X-inactivation
The cytosine at position -43 of the XIST promoter may play an important role in the Xinactivation process: X chromosomes harbouring a cytosine to guanine C(-43)G mutation at this position were preferentially inactivated in females of two unrelated families (13) .
Conversely, a cytosine to adenosine mutation at the same position, C(-43)A on the ring X chromosome of a young girl was associated with escape from X inactivation (14). Since these mutations are located in the middle of fragment 8 of the XIST promoter, which is conserved among mammals and contains a target for CTCF, it seemed possible that these mutations might affect CTCF binding.
To examine this possibility, we used EMSA to test a 140 bp fragments of the human XIST promoter from -108 to + 31 containing a wild type sequence or the same fragment with either the C(-43)G or the C(-43)A mutation (Fig. 3A) . While the C(-43)G mutation dramatically enhanced the affinity of CTCF binding in comparison with the wild type probe, CTCF binding was abolished by the C(-43)A mutation (Fig. 3B ). This result observed with in vitro translated CTCF protein, was also seen with nuclear extracts from various cells (Fig. 3B , and data not shown). The specificity of CTCF-binding in nuclear extracts was confirmed by a super-shift EMSA with CTCF antibodies (Fig. 3B ). Promoter fragments with either the wild type sequence or with the C(-43)G mutation were efficiently bound by CTCF and the resulting CTCF/DNA-complexes were super-shifted with antibodies against CTCF (Fig. 3B) .
In a sharp contrast, no CTCF-DNA interactions could be detected with a fragment containing the C(-43)A-mutation or the "dG-contacts mutation" shown in Figure 3 . The latter mutation was designed to eliminate CTCF binding by mutating a string of six major CTCF-contacting guanines (Fig. 3A) . Those guanines were identified as bases involved in recognition of XIST by the 11 Zn-finger domain of CTCF by DMS methylation interference assay (Fig. 5) . Thus, the C(-43)A mutation eliminates CTCF binding as efficiently as the designed dG-contacts mutation that destroys the CTCF-recognition sequence. These data were additionally supported by the results shown in Figure 4B . In that set of experiments, a radioactive high affinity probe of the chicken FII insulator (24) (Fig. 7) . Following transfection and neomycin selection, we scored for numbers of colonies. In this assay, the insulator strength is inversely proportional to the numbers of surviving cells that register as neomycin-resistant colonies (24) . Figure 7 shows that mouse and human wild-type CTCF-binding region, or the C(-43)A and dGcontacts mutant XIST promoter fragments, do not noticeably reduce the number of colonies when compared to the transfection control used in the enhancer-blocking assay. In a sharp contrast, the same transfection-selection assay with the same plasmid except introducing of the C(-43)G mutation, results in a significantly reduced colony numbers. This result strengthens the link between CTCF binding efficiency and functional properties at the XIST promoter.
Discussion
The convergence of C->A and C->G mutations at the same (-43) position upstream of the XIST +1 transcription start site and their association to opposite patterns of X chromosome inactivation (13, 14) potentially provides an important opening with respect to our observations raise an interesting possibility that BORIS may participate in the choice mechanism for XCI, being expressed at the "right place at right time".
In conclusion, our results indicate a close association between the choice of the future, inactive X chromosome and binding properties of a CTCF target site in the XIST promoter.
Irrespective of the underlying mechanisms, it is remarkable that a point mutation at a single, but pivotal CTCF target site on one of the X chromosomes can be linked to the activation or inactivation of the opposite chromosome in humans. We postulate here that this process requires the CTCF-dependent organization of higher order chromatin conformation that impinges on the stability of the CTCF-XIST promoter complex during early stages of X inactivation.
Materials and Methods
Tissue and cell materials 
Plasmid constructs
The PCR fragment of the human, CTCF-positive XIST minimal promoter was cloned into the Both the naturally occurring C(-43)G and C(-43)A mutations, and the artificial GCCCCCC/AAAGCTT mutation (named "dG-contacts mutation"), were generated in the wtXIST-pCRII-TOPO plasmid by the QuikChange site-directed mutagenesis kit (Stratagene).
DNA sequencing on Li-Cor Sequencer confirmed the accuracy of the cloning as well as the 25 mutagenesis of the insert. These plasmids (wild-type, the C(-43)G mutation, and the C(-43)A mutation, and the dG-contacts mutation from the XIST-pCRII-TOPO based vectors were used for generating of insulator constructs, and as the templates for DNase I footprinting and methylation interference analyses.
The insulator assay series of plasmids were generated on the basis of pJC 5-4 plasmid as has been described earlier (32) . The HS4 globin insulator was inserted into SacI site of the parent plasmid between an enhancer and the mouse γ-globin promoter-Neo reporter gene. To substitute this Sac I HS4 insulator with the wild type, C(-43)G mutant, C(-43)A mutant and "dG" mutant XIST promoter fragments, the inserts were cut out by Sac I enzyme from the corresponding pCRII-TOPO-based constructs which described above, and ligated into the Sac I site of the pJC 5-4 plasmid. To normalize the colony number, we used pJC 5-4 vector with deleted HS4 globin insulator.
Nuclear extracts and in vitro transcription-translation
Full-length human CTCF and the 11ZF CTCF-binding domain were in vitro translated from pET-7.1 and pET-11ZF, respectively(33), using the TnT reticulocyte lysate-coupled in vitro incubated with CTCF and then partially digested with DNase I, or partially methylated at guanine residues by dimethyl sulfate and then incubated with CTCF, as has been described (27) .
Insulator assay
Insulator assays were performed in human K562 erythroleukemia cells as has been described While identical nucleotides are outlined in red font, the differences are indicated in blue font.
Four nucleotides, opposite to four single nucleotide gaps introduced to achieve the highest 
